Publicaciones en las que colabora con Carlos Caramelo (68)

2012

  1. AG490 promotes HIF-1α accumulation by inhibiting its hydroxylation

    Current Medicinal Chemistry, Vol. 19, Núm. 23, pp. 4014-4023

2009

  1. Inhibition of JAK2 protects renal endothelial and epithelial cells from oxidative stress and cyclosporin A toxicity

    Kidney International, Vol. 75, Núm. 2, pp. 227-234

2008

  1. Nephrotoxicity

    Drug-Induced Mitochondrial Dysfunction (John Wiley & Sons, Inc.), pp. 291-310

  2. Sueros empleados en enfermos quirúrgicos: Composición y efectos sobre el medio interno

    Nefrologia, Vol. 28, Núm. 1, pp. 37-42

  3. Vigencia de la acetazolamida en la terapéutica diurética actual: Aplicaciones en el edema refractario y la hiperpotasemia relacionada al bloqueo aldosterónico

    Nefrologia, Vol. 28, Núm. 2, pp. 234-238

2007

  1. Cilastatin protection against cyclosporin A-induced nephrotoxicity: Clinical evidence

    Current Medical Research and Opinion, Vol. 23, Núm. 3, pp. 505-513

2006

  1. Impact of end-stage renal disease care in planned dialysis start and type of renal replacement therapy - A Spanish multicentre experience

    Nephrology Dialysis Transplantation, Vol. 21, Núm. SUPPL. 2

2004

  1. Cyclosporin A toxicity, and more: Vascular endothelial growth factor (VEGF) steps forward

    Nephrology Dialysis Transplantation

2001

  1. Development of porphyria cutanea tarda in a hemodialysis patient after reactivation of hepatitis C virus infection

    Nephron, Vol. 88, Núm. 2, pp. 170-173

  2. Impairment of renal vasodilation with L-arginine is related to more severe disease in untreated hypertensive patients

    Hypertension, Vol. 38, Núm. 4, pp. 907-912

  3. Role of type of vascular access in erythropoietin and intravenous iron requirements in haemodialysis

    Nephrology Dialysis Transplantation, Vol. 16, Núm. 11, pp. 2188-2193

  4. Structural changes and vascular calcifications in uremia

    Nefrología : publicación oficial de la Sociedad Española Nefrologia, Vol. 21, Núm. 6, pp. 538-547

2000

  1. Antiplatelet therapy alters iron requirements in hemodialysis patients

    American Journal of Kidney Diseases, Vol. 36, Núm. 1, pp. 80-87

  2. Role of haemodialysis and hepatitis C virus infection in spontaneous and induced cytokine production of patients with chronic renal disease

    Cytokine, Vol. 12, Núm. 8, pp. 1248-1252

  3. Role of vascular endothelial growth factor (VEGF) in endothelial cell protection against cytotoxic agents

    Life Sciences, Vol. 67, Núm. 9, pp. 1003-1013

1999

  1. Cinetica del interferon α-2a en pacientes en hemodialisis

    Nefrologia, Vol. 19, Núm. 3, pp. 268-270

  2. GBV-C/HGV-RNA in serum and peripheral blood mononuclear cells in hemodialysis patients

    Kidney International, Vol. 56, Núm. 3, pp. 1120-1128

  3. Hand-borne mechanisms of dissemination of hepatitis C virus in dialysis units: Basis for new addenda to the present preventive strategies [1]

    Clinical Nephrology

  4. Hyperkalemia in patients infected with the human immunodeficiency virus: Involvement of a systemic mechanism

    Kidney International, Vol. 56, Núm. 1, pp. 198-205

  5. Induction of microalbuminuria by L-arginine infusion in healthy individuals: An insight into the mechanisms of proteinuria

    American Journal of Kidney Diseases, Vol. 33, Núm. 6, pp. 1018-1025